FDA, Weight Loss and warning letter
Digest more
COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent infringement after the U.S. telehealth firm launched, then cancelled, a $49 copy of Novo's weight-loss ...
The newly-approved device requires only that patients swallow it in their doctor's office to achieve weight loss, according ...
Alternatives to Ozempic for Weight Loss This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an ...
The U.S. Food and Drug Administration approved a once-daily pill version of Novo Nordisk’s blockbuster GLP-1 weight loss drug Wegovy. The FDA made the decision Dec. 22. The starting dose of 1.5 ...
Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...
The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results